Cargando…
CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule
BACKGROUND: We recently reported the relapse-free survival (RFS) significance of the combination of CD4(+) and forkhead box P3(+) (FOXP3) T-cell densities identified by immunohistochemistry in patients with stage I, II, and III colorectal cancer (CRC) who underwent curative resections. This study wa...
Autores principales: | Nakagami, Yuki, Hazama, Shoichi, Suzuki, Nobuaki, Yoshida, Shin, Tomochika, Shinobu, Matsui, Hiroto, Shindo, Yoshitaro, Tokumitsu, Yukio, Matsukuma, Satoshi, Watanabe, Yusaku, Iida, Michihisa, Tsunedomi, Ryouichi, Takeda, Shigeru, Fujita, Tomonobu, Kawakami, Yutaka, Ogihara, Hiroyuki, Hamamoto, Yoshihiko, Ioka, Tatsuya, Tanabe, Tsuyoshi, Ueno, Tomio, Nagano, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578193/ https://www.ncbi.nlm.nih.gov/pubmed/36253752 http://dx.doi.org/10.1186/s12885-022-10181-7 |
Ejemplares similares
-
Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
por: Kuwahara, Taichi, et al.
Publicado: (2019) -
Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
por: Kuwahara, Taichi, et al.
Publicado: (2019) -
Siglec-7 is a predictive biomarker for the efficacy of cancer vaccination against metastatic colorectal cancer
por: Yamada, Kensuke, et al.
Publicado: (2021) -
Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity
por: Kanesada, Kou, et al.
Publicado: (2022) -
Determining the protective characteristics and risk factors for the development of anastomotic leakage after low anterior resection for rectal cancer
por: Suzuki, Nobuaki, et al.
Publicado: (2020)